August 10, 2020 1:12:28 pm
Shares of drug firm Cipla on Monday jumped 10 per cent after the company reported a 26.58 per cent rise in its consolidated net profit for the quarter ended June.
The company’s stock zoomed 9.99 per cent to Rs 801.45 — its 52-week high — on the BSE.
It rose sharply by 9.99 per cent to its one-year high of Rs 801.50 on the NSE.
The drug firm on Friday reported a 26.58 per cent rise in its consolidated net profit to Rs 566.04 crore for the quarter ended June on the back of robust sales.
The company had posted a net profit of Rs 447.15 crore for the corresponding period of the previous fiscal, Cipla said in a BSE filing.
Total revenue from operations for the quarter under consideration stood at Rs 4,346.16 crore. It was Rs 3,989.02 crore for the same period year ago, it added.
“During the quarter, our businesses actively re-imagined their operating models to drive strong growth across markets of India, South Africa, the US and focused execution on cost optimization helped drive the quarter EBITDA to 24 per cent,” Cipla MD and Global CEO Umang Vohra said.
The company is also at the forefront in combating COVID-19 through its strategic partnerships and a spectrum of offerings in its portfolio, he added.
📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines
- The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.